ArticleActa obstetricia et gynecologica Scandinavica2026
Home telemonitoring in high-risk pregnancies: A Finnish retrospective cohort study.
Article in Acta obstetricia et gynecologica Scandinavica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
introductionHigh-risk pregnancies require close monitoring and frequent hospital visits. Home telemonitoring offers a potential alternative to improve access and satisfaction while reducing healthcare use. This retrospective cohort study characterized the clinical course and events during home telemonitoring including home-based cardiotocography during a pilot program for women with high-risk pregnancies at an urban tertiary hospital. MATERIAL AND
methodsThis retrospective three-year cohort study included 117 singleton pregnancies enrolled in a home telemonitoring program at Helsinki University Hospital between January 2021 and December 2023. Participants were grouped by primary indication: premature rupture of membranes, preeclampsia and/or fetal growth restriction, or other high-risk conditions. The main outcomes included the course and duration of home telemonitoring, rates of hospital visits and readmissions, the onset of labor or emergency cesarean delivery, and severe complications during home telemonitoring, including maternal or fetal death, placental abruption, prolapse of umbilical cord, placenta previa with bleeding, chorioamnionitis, eclampsia, and worsening of preeclampsia.
resultsThe median gestational age at initiation of home telemonitoring was 32.4 weeks, and the median monitoring duration was 7 days (IQR 2.5-13.5). Thirty-eight women (32.6%) were readmitted. The median gestational age at delivery was 34.6 (range 25.1-41.4) weeks, and 87.2% (102/117) delivered preterm. The overall cesarean rate was 47.0% (55/117). Spontaneous onset of labor occurred in 11 (9.4%) women during the home telemonitoring period; no home deliveries were recorded. 38 women (32.5%) underwent an emergency cesarean delivery. No maternal or intrauterine fetal deaths occurred. Complications occurred in 36 cases (30.8%). The most common complications were chorioamnionitis (n = 21,17.9%) and worsening of preeclampsia (n = 11, 9.4%). No eclampsia was observed. Two cases of placental abruption (n = 2, 1.7%) and two cases of bleeding due to placenta previa (n = 2, 1.7%) occurred. In all the preceding cases, immediate readmission and prompt management resulted in favorable maternal and neonatal outcomes.
conclusionsThis pilot study suggests that home telemonitoring represents an acceptable approach for the management of selected high-risk pregnancies. However, careful patient selection and strict adherence to evidence-based clinical protocols are essential to ensure safe and effective implementation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.